Healthcare >> CEO Interviews >> December 18, 2000
MICHAEL G. HANNA, JR., PhD, is Chairman of the Board, President, and
Chief Scientific Officer of Intracel Corporation, a biomedical research
and development company in Rockville, Maryland. From 1996 to 1998, Dr.
Hanna served as President and Chief Executive Officer of PerImmune,
Inc., a company he founded which resulted as a management buy-out from
Akzo Nobel in July 1996. In 1998, PerImmune Inc. merged with Intracel
Corporation. From 1985 to 1996, Dr. Hanna served as Chief Operating
Officer of the Biotechnology Research Institute of Akzo Nobel NV, The
Netherlands. Dr. Hanna founded the Litton Institute of Applied
Biotechnology (LIAB) in 1982. In 1985, Organon Teknika assumed
operations of LIAB and he served as Senior Vice President of Organon
Teknika. Prior to his position at LIAB in 1982, Dr. Hanna served as the
Director of the National Cancer Institute, Frederick Cancer Research
Center from 1975 to 1982. Prior to 1975, Dr. Hanna was a staff
scientist at the Oak Ridge National Laboratory, Biology Division, in Oak
Ridge, Tennessee. Profile
Corporation?
Dr. Hanna: INTRACEL is a biopharmaceutical company developing and
commercializing vaccines and
